Poly Medicure Limited (NSE:POLYMED)
1,384.40
-35.40 (-2.49%)
Jun 8, 2026, 3:30 PM IST
Poly Medicure Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Poly Medicure stock has a consensus rating of "Hold" and an average price target of ₹1,579. The average 1-year stock price forecast is 14.04% higher than the current stock price, while the lowest is ₹1,230 (-11.15%) and the highest is ₹2,050 (+48.08%).
Price Target: ₹1,579 (+14.04%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Poly Medicure stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 1 | 1 | 1 | 2 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
23.71B
from 18.75B
Increased by 26.41%
Revenue Next Year
27.12B
from 23.71B
Increased by 14.39%
EPS This Year
38.65
from 31.24
Increased by 23.70%
EPS Next Year
46.87
from 38.65
Increased by 21.26%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 25.1B | ||
| Avg | 23.7B | ||
| Low | 22.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 34.0% | ||
| Avg | 26.4% | ||
| Low | 20.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 38.65 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 23.7% | ||
| Low | - |